# Theophylline in Treating Cancer Patients With Shortness of Breath

> **NCT00003684** · PHASE3 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 3 (actual)

## Conditions studied

- Pulmonary Complications
- Quality of Life
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** theophylline
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00003684
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-03-24
- **Primary completion:** 2008-12-15
- **Final completion:** 2008-12-15
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003684, "Theophylline in Treating Cancer Patients With Shortness of Breath". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00003684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*